AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
Efficacy and safety of hydroxyurea in patients with essential thrombocythemia
Authors: Finazzi, G Barbui, T
Citation: G. Finazzi et T. Barbui, Efficacy and safety of hydroxyurea in patients with essential thrombocythemia, PATH BIOL, 49(2), 2001, pp. 167-169
Photoinhibition of Chlamydomonas reinhardtii in State 1 and State 2 - Damages to the photosynthetic apparatus under linear and cyclic electron flow
Authors: Finazzi, G Barbagallo, RP Bergo, E Barbato, R Forti, G
Citation: G. Finazzi et al., Photoinhibition of Chlamydomonas reinhardtii in State 1 and State 2 - Damages to the photosynthetic apparatus under linear and cyclic electron flow, J BIOL CHEM, 276(25), 2001, pp. 22251-22257
Contrasted effects of inhibitors of cytochrome b(6)f complex on state transitions in Chlamydomonas reinhardtii - The role of Q(o) site occupancy in LHCII kinase activation
Authors: Finazzi, G Zito, F Barbagallo, RP Wollman, FA
Citation: G. Finazzi et al., Contrasted effects of inhibitors of cytochrome b(6)f complex on state transitions in Chlamydomonas reinhardtii - The role of Q(o) site occupancy in LHCII kinase activation, J BIOL CHEM, 276(13), 2001, pp. 9770-9774
Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG
Authors: Michiels, JJ Barbui, T Finazzi, G Fuchtman, SM Kutti, J Rain, JD Silver, RT Tefferi, A Thiele, J
Citation: Jj. Michiels et al., Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG, LEUK LYMPH, 36(3-4), 2000, pp. 239-253
Diagnosis of essential thrombocythemia at platelet counts between 400 and 600x10(9)/L
Authors: Sacchi, S Vinci, G Gugliotta, L Rupoli, S Gargantini, L Martinelli, V Baravelli, S Lazzarino, M Finazzi, G
Citation: S. Sacchi et al., Diagnosis of essential thrombocythemia at platelet counts between 400 and 600x10(9)/L, HAEMATOLOG, 85(5), 2000, pp. 492-495
Kinetic effects of the electrochemical proton gradient on plastoquinone reduction at the Qi site of the cytochrome b(6)f complex
Authors: Barbagallo, RP Breyton, C Finazzi, G
Citation: Rp. Barbagallo et al., Kinetic effects of the electrochemical proton gradient on plastoquinone reduction at the Qi site of the cytochrome b(6)f complex, J BIOL CHEM, 275(34), 2000, pp. 26121-26127
Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study
Authors: Chopra, R Eaton, JD Grassi, A Potter, M Shaw, B Salat, C Neumeister, P Finazzi, G Iacobelli, M Bowyer, K Prentice, HG Barbui, T
Citation: R. Chopra et al., Defibrotide for the treatment of hepatic veno-occlusive disease: results of the European compassionate-use study, BR J HAEM, 111(4), 2000, pp. 1122-1129
Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trial
Authors: Finazzi, G Ruggeri, M Rodeghiero, F Barbui, T
Citation: G. Finazzi et al., Second malignancies in patients with essential thrombocythaemia treated with busulphan and hydroxyurea: long-term follow-up of a randomized clinical trial, BR J HAEM, 110(3), 2000, pp. 577-583
The G1691 -> A mutation of factor V, but not the G20210 -> A mutation of factor II or the C677 -> T mutation of methylenetetrahydrofolate reductase genes, is associated with venous thrombosis in patients with lupus anticoagulants
Authors: Galli, M Finazzi, G Duca, F Norbis, F Moia, M
Citation: M. Galli et al., The G1691 -> A mutation of factor V, but not the G20210 -> A mutation of factor II or the C677 -> T mutation of methylenetetrahydrofolate reductase genes, is associated with venous thrombosis in patients with lupus anticoagulants, BR J HAEM, 108(4), 2000, pp. 865-870
Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera
Authors: Falanga, A Marchetti, M Evangelista, V Vignoli, A Licini, M Balicco, M Manarini, S Finazzi, G Cerietti, C Barbui, T
Citation: A. Falanga et al., Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera, BLOOD, 96(13), 2000, pp. 4261-4266
Recurrence after first cerebral infarction in young adults
Authors: Camerlingo, M Casto, L Censori, B Ferraro, B Caverni, L Manara, O Finazzi, G Radice, E Drago, G De Tommasi, SM Gotti, E Barbui, T Mamoli, A
Citation: M. Camerlingo et al., Recurrence after first cerebral infarction in young adults, ACT NEUR SC, 102(2), 2000, pp. 87-93
Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance - A multicenter collaborative family study
Authors: Bucciarelli, P Rosendaal, FR Tripodi, A Mannucci, PM De Stefano, V Palareti, G Finazzi, G Baudo, F Quintavalla, R
Citation: P. Bucciarelli et al., Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance - A multicenter collaborative family study, ART THROM V, 19(4), 1999, pp. 1026-1033
Management of essential thrombocythemia
Authors: Barbui, T Finazzi, G
Citation: T. Barbui et G. Finazzi, Management of essential thrombocythemia, CR R ONC H, 29(3), 1999, pp. 257-266
Analysis of the nucleus-encoded and chloroplast-targeted rieske protein byclassic and site-directed mutagenesis of Chlamydomonas
Authors: de Vitry, C Finazzi, G Baymann, F Kallas, T
Citation: C. De Vitry et al., Analysis of the nucleus-encoded and chloroplast-targeted rieske protein byclassic and site-directed mutagenesis of Chlamydomonas, PL CELL, 11(10), 1999, pp. 2031-2044
Treatment of essential thrombocythemia with special emphasis on leukemogenic risk
Authors: Finazzi, G Barbui, T
Citation: G. Finazzi et T. Barbui, Treatment of essential thrombocythemia with special emphasis on leukemogenic risk, ANN HEMATOL, 78(9), 1999, pp. 389-392
The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile
Authors: Galli, M Finazzi, G Norbis, F Marziali, S Marchioli, R Barbui, T
Citation: M. Galli et al., The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile, THROMB HAEM, 81(5), 1999, pp. 695-700
Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis
Authors: Michiels, JJ Kutti, J Stark, P Bazzan, M Gugliotta, L Marchioli, R Griesshammer, M van Genderen, PJJ Briere, J Kiladjian, JJ Barbui, T Finazzi, G Berlin, NI Pearson, TC Green, AC Fruchtmann, SM Silver, RT Hansmann, E Wehmeier, A Lengfelder, E Landolfi, R Kvasnicka, HM Hasselbalch, H Cervantes, F Reilly, JT Demory, JL Gisslinger, H Guardiola, P Martyre, MC Le Bousse-Kerdiles, MC Thiele, J
Citation: Jj. Michiels et al., Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis, NETH J MED, 54(2), 1999, pp. 46-62
The Qo site of cytochrome b(6)f complexes controls the activation of the LHCII kinase
Authors: Zito, F Finazzi, G Delosme, R Nitschke, W Picot, D Wollman, FA
Citation: F. Zito et al., The Qo site of cytochrome b(6)f complexes controls the activation of the LHCII kinase, EMBO J, 18(11), 1999, pp. 2961-2969
Clinical parameters for determining when and when not to treat essential thrombocythemia
Authors: Barbui, T Finazzi, G
Citation: T. Barbui et G. Finazzi, Clinical parameters for determining when and when not to treat essential thrombocythemia, SEM HEMATOL, 36(1), 1999, pp. 14-18
The management of 'low-risk' and 'intermediate-risk' patients with primarythrombocythaemia
Authors: Ruggeri, M Tosetto, A Rodeghiero, F Finazzi, G Barbui, T
Citation: M. Ruggeri et al., The management of 'low-risk' and 'intermediate-risk' patients with primarythrombocythaemia, BR J HAEM, 106(3), 1999, pp. 834-834
Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (Factor V leiden)
Authors: Faioni, EM Franchi, F Bucciarelli, P Margaglione, M De Stefano, V Castaman, G Finazzi, G Mannucci, PM
Citation: Em. Faioni et al., Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (Factor V leiden), BLOOD, 94(9), 1999, pp. 3062-3066
A new electrochemical gradient generator in thylakoid membranes of green algae
Authors: Rappaport, F Finazzi, G Pierre, Y Bennoun, P
Citation: F. Rappaport et al., A new electrochemical gradient generator in thylakoid membranes of green algae, BIOCHEM, 38(7), 1999, pp. 2040-2047
Effects of inhibitors on the activity of the cytochrome b(6)f complex: Evidence for the existence of two binding pockets in the lumenal site
Authors: Barbagallo, RP Finazzi, G Forti, G
Citation: Rp. Barbagallo et al., Effects of inhibitors on the activity of the cytochrome b(6)f complex: Evidence for the existence of two binding pockets in the lumenal site, BIOCHEM, 38(39), 1999, pp. 12814-12821
State transitions, cyclic and linear electron transport and photophosphorylation in Chlamydomonas reinhardtii
Authors: Finazzi, G Furia, A Barbagallo, RP Forti, G
Citation: G. Finazzi et al., State transitions, cyclic and linear electron transport and photophosphorylation in Chlamydomonas reinhardtii, BBA-BIOENER, 1413(3), 1999, pp. 117-129
Chronic myeloid disorders, excluding CML
Authors: Barbui, T Finazzi, G Barosi, G
Citation: T. Barbui et al., Chronic myeloid disorders, excluding CML, TEXTBOOK OF MALIGNANT HAEMATOLOGY, 1999, pp. 847-869
Risultati: 1-25 | 26-28